Author: Sat, 2021-02-27 10:17 DUBAI: Bahrain has announced it is increasing the number of weeks between the first and second dose of the Covishield-AstraZeneca vaccine from four to eight weeks, state news agency BNA reported. The World Health Organization (WHO) said the longer dose durations between eight to 12 weeks are related to greater vaccine effectiveness, the Ministry of Health’s Undersecretary for Public Health Dr. Mariam Al-Hajeri said. The vaccine was approved for emergency use for vulnerable groups in the Kingdom starting Jan. 21. The groups include the elderly and those with immune complications, she said. The vaccine was produced by AstraZeneca in cooperation with the Univer
Hence then, the article about bahrain announces extension of covishield astrazeneca dosing intervals was published today ( ) and is available onARAB NEWS ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Bahrain announces extension of Covishield-AstraZeneca dosing intervals )